India's Venus Remedies up 3% on securing GMP certification from Kenya

Venus Remedies

23/05/2023 08:06

** Shares of Venus Remedies Ltd  VENR.NS  rise as much as
3.64% to 205 rupees
    ** Uptick after the research-based pharmaceutical company
secures a "good manufacturing practices" (GMP) certification
from Kenya for its product facilities in Baddi in Himachal
Pradesh
    ** The GMP from Kenya, estimated to be a $780 million
market, is likely to bolster VENR's reach in African market,
company adds
    ** VENR already has presence in Uganda, Tanzania, Kenya and
Rwanda in the continent
    ** Trading volume is 42,833 shares as of 12:33 p.m. IST,
0.6x the 30-day avg - Refinitiv data
    
     ($1 = 81.7800 Indian rupees)

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))